Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
ARWRArrowhead Pharmaceuticals	$8.86bn	41.06	n/a
CRLCharles River Laboratories International	$8.79bn	53.39	n/a
IMGNImmunoGen	$8.72bn	n/a	n/a
BPMCBlueprint Medicines	$8.37bn	n/a	n/a
ICLRIcon	$8.26bn	10.65	n/a
CERECerevel Therapeutics Holdings	$8.19bn	n/a	n/a
NUVLNuvalent	$8.02bn	n/a	n/a
CYTKCytokinetics	$7.66bn	n/a	n/a
KYMRKymera Therapeutics	$7.43bn	n/a	n/a
MRUSMerus NV	$7.35bn	n/a	n/a
CDTXCidara Therapeutics	$6.95bn	n/a	n/a
ACLXArcellx	$6.65bn	n/a	n/a
RETAReata Pharmaceuticals	$6.52bn	n/a	n/a
COGTCogent Biosciences	$6.31bn	n/a	n/a
BLTEBelite Bio	$6.20bn	n/a	n/a
PTGXProtagonist Therapeutics	$5.88bn	n/a	n/a
CRSPCrispr Therapeutics AG	$5.77bn	n/a	n/a
IMVTImmunovant	$5.64bn	n/a	n/a
MTSRMetsera	$5.58bn	n/a	n/a
ISEEIVERIC bio	$5.51bn	n/a	n/a